Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit and Disruptive Behavior Disorders

Explore clinical trials studying Attention Deficit and Disruptive Behavior Disorders. Study availability and eligibility vary by location and protocol.

1,451 public trials 168 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit and Disruptive Behavior Disorders trial results

Completed

Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment

NCT00343811

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • UCI Child Development Center Irvine, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • Encompass Clinical Research Spring Valley, California, United States
View all 23 locations
View Trial Details
Completed

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

NCT00228540

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Melmed Center Scottsdale, Arizona, United States
  • UCI Child Development Center Irvine, California, United States
  • Pharmacology Research Institut Northridge, California, United States
  • Pacific Sleep Medicine Service San Diego, California, United States
View all 39 locations
View Trial Details
Completed

A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder

NCT00714688

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/ Hyperactivity Disorder, +2 more
Locations
  • Antwerp, Belgium
  • Brussels, Belgium
  • Kortenberg, Belgium
  • Mechelen, Belgium
View all 42 locations
View Trial Details
Completed

Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00307684

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Paris, France
  • Ahrensburg, Germany
  • Aschaffenburg, Germany
  • Berlin, Germany
View all 21 locations
View Trial Details

Related conditions